In Vivo Screening Data Summary

NCI In Vivo Screening Data

Sarcoma M5076 (intraperitoneal) in B6C3F1 mice

NSC 362856
CAS 85622-93-1
Temozolomide; Methazolastone; Temodar

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q04DX004 (ip) median survival time saline 50.0 mg/kg/injection 142.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 14
Q04DX004 (ip) median survival time saline 100.0 mg/kg/injection 156.0 Antitumor endpoint evaluated on day 60; 09/10 animals surviving on day 14
Q04DX004 (ip) median survival time saline 200.0 mg/kg/injection 170.0 Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 14
Q04DX004 (ip) median survival time saline 400.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 00/10 animals surviving on day 14
Q04DX004 (ip) median survival time saline 800.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 60; 00/10 animals surviving on day 14